Nosocomial Infection Treatment Market Report

Global and Region Nosocomial Infection Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：203
  • REPORT CODE：GMM971494
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Nosocomial Infection Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Nosocomial Infection Treatmentmarket, defines the market attractiveness level of Nosocomial Infection Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Nosocomial Infection Treatment industry, describes the types of Nosocomial Infection Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nosocomial Infection Treatment market and the development prospects and opportunities of Nosocomial Infection Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nosocomial Infection Treatment market in Chapter 13.

    By Player:

    • Halyard Health, Inc

    • Matachana Group

    • Sakura Seiki

    • Cantel

    • Roche

    • Nordion

    • Johnson and Johnson

    • Getinge Group

    • BioMérieux

    • Belimed

    • Steris

    • Sterigenics International, Inc

    • Abbott

    • Merck and Co

    • Bayer

    • BioMerieux

    • Kimberly-Clark Corp

    • Cepheid

    • Advanced Sterilization Products

    • Becton, Dickinson and Company

    • Pfizer

    By Type:

    • Antibacterial Treatment

    • Antiviral Treatment

    • Antifungal Treatment

    By End-User:

    • Ventilator Associated Pneumonia

    • Urinary Tract Infection

    • Blood Stream Infection

    • Surgical Site Infection

    • Gastrointestinal Infection

    • MRSA

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Nosocomial Infection Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Nosocomial Infection Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Nosocomial Infection Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Nosocomial Infection Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Nosocomial Infection Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Nosocomial Infection Treatment Consumption (2017-2022)

    • 7.2 United States Nosocomial Infection Treatment Consumption (2017-2022)

    • 7.3 Europe Nosocomial Infection Treatment Consumption (2017-2022)

    • 7.4 China Nosocomial Infection Treatment Consumption (2017-2022)

    • 7.5 Japan Nosocomial Infection Treatment Consumption (2017-2022)

    • 7.6 India Nosocomial Infection Treatment Consumption (2017-2022)

    • 7.7 South Korea Nosocomial Infection Treatment Consumption (2017-2022)

    8 Region and Country-wise Nosocomial Infection Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Nosocomial Infection Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Nosocomial Infection Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Nosocomial Infection Treatment Consumption Forecast (2022-2028)

    • 8.4 China Nosocomial Infection Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Nosocomial Infection Treatment Consumption Forecast (2022-2028)

    • 8.6 India Nosocomial Infection Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Nosocomial Infection Treatment Consumption Forecast (2022-2028)

    9 Global Nosocomial Infection Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Nosocomial Infection Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Antibacterial Treatment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antiviral Treatment Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Antifungal Treatment Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nosocomial Infection Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Ventilator Associated Pneumonia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Blood Stream Infection Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Surgical Site Infection Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Gastrointestinal Infection Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global MRSA Consumption and Growth Rate (2017-2022)

    10 Global Nosocomial Infection Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Nosocomial Infection Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Antibacterial Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Antiviral Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Antifungal Treatment Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Nosocomial Infection Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Ventilator Associated Pneumonia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Blood Stream Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Surgical Site Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Gastrointestinal Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global MRSA Consumption Forecast and Growth Rate (2022-2028)

    11 Global Nosocomial Infection Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Nosocomial Infection Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Nosocomial Infection Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Nosocomial Infection Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Nosocomial Infection Treatment Market Competitive Analysis

    • 14.1 Halyard Health, Inc

      • 14.1.1 Halyard Health, Inc Company Details

      • 14.1.2 Halyard Health, Inc Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Halyard Health, Inc Nosocomial Infection Treatment Product and Service

    • 14.2 Matachana Group

      • 14.2.1 Matachana Group Company Details

      • 14.2.2 Matachana Group Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Matachana Group Nosocomial Infection Treatment Product and Service

    • 14.3 Sakura Seiki

      • 14.3.1 Sakura Seiki Company Details

      • 14.3.2 Sakura Seiki Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sakura Seiki Nosocomial Infection Treatment Product and Service

    • 14.4 Cantel

      • 14.4.1 Cantel Company Details

      • 14.4.2 Cantel Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Cantel Nosocomial Infection Treatment Product and Service

    • 14.5 Roche

      • 14.5.1 Roche Company Details

      • 14.5.2 Roche Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Roche Nosocomial Infection Treatment Product and Service

    • 14.6 Nordion

      • 14.6.1 Nordion Company Details

      • 14.6.2 Nordion Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Nordion Nosocomial Infection Treatment Product and Service

    • 14.7 Johnson and Johnson

      • 14.7.1 Johnson and Johnson Company Details

      • 14.7.2 Johnson and Johnson Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson and Johnson Nosocomial Infection Treatment Product and Service

    • 14.8 Getinge Group

      • 14.8.1 Getinge Group Company Details

      • 14.8.2 Getinge Group Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Getinge Group Nosocomial Infection Treatment Product and Service

    • 14.9 BioMérieux

      • 14.9.1 BioMérieux Company Details

      • 14.9.2 BioMérieux Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 BioMérieux Nosocomial Infection Treatment Product and Service

    • 14.10 Belimed

      • 14.10.1 Belimed Company Details

      • 14.10.2 Belimed Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Belimed Nosocomial Infection Treatment Product and Service

    • 14.11 Steris

      • 14.11.1 Steris Company Details

      • 14.11.2 Steris Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Steris Nosocomial Infection Treatment Product and Service

    • 14.12 Sterigenics International, Inc

      • 14.12.1 Sterigenics International, Inc Company Details

      • 14.12.2 Sterigenics International, Inc Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Sterigenics International, Inc Nosocomial Infection Treatment Product and Service

    • 14.13 Abbott

      • 14.13.1 Abbott Company Details

      • 14.13.2 Abbott Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Abbott Nosocomial Infection Treatment Product and Service

    • 14.14 Merck and Co

      • 14.14.1 Merck and Co Company Details

      • 14.14.2 Merck and Co Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Merck and Co Nosocomial Infection Treatment Product and Service

    • 14.15 Bayer

      • 14.15.1 Bayer Company Details

      • 14.15.2 Bayer Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Bayer Nosocomial Infection Treatment Product and Service

    • 14.16 BioMerieux

      • 14.16.1 BioMerieux Company Details

      • 14.16.2 BioMerieux Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 BioMerieux Nosocomial Infection Treatment Product and Service

    • 14.17 Kimberly-Clark Corp

      • 14.17.1 Kimberly-Clark Corp Company Details

      • 14.17.2 Kimberly-Clark Corp Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Kimberly-Clark Corp Nosocomial Infection Treatment Product and Service

    • 14.18 Cepheid

      • 14.18.1 Cepheid Company Details

      • 14.18.2 Cepheid Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Cepheid Nosocomial Infection Treatment Product and Service

    • 14.19 Advanced Sterilization Products

      • 14.19.1 Advanced Sterilization Products Company Details

      • 14.19.2 Advanced Sterilization Products Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Advanced Sterilization Products Nosocomial Infection Treatment Product and Service

    • 14.20 Becton, Dickinson and Company

      • 14.20.1 Becton, Dickinson and Company Company Details

      • 14.20.2 Becton, Dickinson and Company Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Becton, Dickinson and Company Nosocomial Infection Treatment Product and Service

    • 14.21 Pfizer

      • 14.21.1 Pfizer Company Details

      • 14.21.2 Pfizer Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Pfizer Nosocomial Infection Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Nosocomial Infection Treatment

    • Figure Nosocomial Infection Treatment Picture

    • Table Global Nosocomial Infection Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nosocomial Infection Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Nosocomial Infection Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Nosocomial Infection Treatment Consumption by Country (2017-2022)

    • Figure United States Nosocomial Infection Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Nosocomial Infection Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Nosocomial Infection Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Nosocomial Infection Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Nosocomial Infection Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nosocomial Infection Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Nosocomial Infection Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Nosocomial Infection Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nosocomial Infection Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Nosocomial Infection Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nosocomial Infection Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nosocomial Infection Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nosocomial Infection Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antibacterial Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Antiviral Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Antifungal Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Ventilator Associated Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Stream Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Surgical Site Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Infection Consumption and Growth Rate (2017-2022)

    • Figure Global MRSA Consumption and Growth Rate (2017-2022)

    • Figure Global Antibacterial Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antiviral Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antifungal Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ventilator Associated Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Stream Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgical Site Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MRSA Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Nosocomial Infection Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Nosocomial Infection Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Halyard Health, Inc (Foundation Year, Company Profile and etc.)

    • Table Halyard Health, Inc Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Halyard Health, Inc Nosocomial Infection Treatment Product and Service

    • Table Matachana Group (Foundation Year, Company Profile and etc.)

    • Table Matachana Group Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Matachana Group Nosocomial Infection Treatment Product and Service

    • Table Sakura Seiki (Foundation Year, Company Profile and etc.)

    • Table Sakura Seiki Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sakura Seiki Nosocomial Infection Treatment Product and Service

    • Table Cantel (Foundation Year, Company Profile and etc.)

    • Table Cantel Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cantel Nosocomial Infection Treatment Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Nosocomial Infection Treatment Product and Service

    • Table Nordion (Foundation Year, Company Profile and etc.)

    • Table Nordion Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Nosocomial Infection Treatment Product and Service

    • Table Johnson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Nosocomial Infection Treatment Product and Service

    • Table Getinge Group (Foundation Year, Company Profile and etc.)

    • Table Getinge Group Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Getinge Group Nosocomial Infection Treatment Product and Service

    • Table BioMérieux (Foundation Year, Company Profile and etc.)

    • Table BioMérieux Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMérieux Nosocomial Infection Treatment Product and Service

    • Table Belimed (Foundation Year, Company Profile and etc.)

    • Table Belimed Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Belimed Nosocomial Infection Treatment Product and Service

    • Table Steris (Foundation Year, Company Profile and etc.)

    • Table Steris Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Steris Nosocomial Infection Treatment Product and Service

    • Table Sterigenics International, Inc (Foundation Year, Company Profile and etc.)

    • Table Sterigenics International, Inc Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sterigenics International, Inc Nosocomial Infection Treatment Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Nosocomial Infection Treatment Product and Service

    • Table Merck and Co (Foundation Year, Company Profile and etc.)

    • Table Merck and Co Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck and Co Nosocomial Infection Treatment Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Nosocomial Infection Treatment Product and Service

    • Table BioMerieux (Foundation Year, Company Profile and etc.)

    • Table BioMerieux Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMerieux Nosocomial Infection Treatment Product and Service

    • Table Kimberly-Clark Corp (Foundation Year, Company Profile and etc.)

    • Table Kimberly-Clark Corp Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kimberly-Clark Corp Nosocomial Infection Treatment Product and Service

    • Table Cepheid (Foundation Year, Company Profile and etc.)

    • Table Cepheid Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cepheid Nosocomial Infection Treatment Product and Service

    • Table Advanced Sterilization Products (Foundation Year, Company Profile and etc.)

    • Table Advanced Sterilization Products Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Sterilization Products Nosocomial Infection Treatment Product and Service

    • Table Becton, Dickinson and Company (Foundation Year, Company Profile and etc.)

    • Table Becton, Dickinson and Company Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton, Dickinson and Company Nosocomial Infection Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Nosocomial Infection Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Nosocomial Infection Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US